Biotech News
AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
investor.an2therapeutics.com2026-05-07 20:08 EST
MENLO PARK, Calif. --(BUSINESS WIRE)--May 7, 2026-- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will participate in